Literature DB >> 15312966

Hippocampal neurons in pre-clinical Alzheimer's disease.

Mark J West1, Claudia H Kawas, Walter F Stewart, Gay L Rudow, Juan C Troncoso.   

Abstract

In a previous study of hippocampal neurons in aging and AD [Lancet 344 (1994) 769], we demonstrated that the loss of neurons in the CA1 region was disease-specific and not related to aging. In the present study, we examined for loss of hippocampal neurons in preclinical AD, a period during which there are abundant amyloid deposits in the brain but no evidence of cognitive decline. We examined the postmortem brains of 33 subjects from the Baltimore Longitudinal Study of Aging and the Johns Hopkins Alzheimer's Disease Research Center. Using unbiased stereology, we estimated the total number of neurons in the granule cell layer, hilus, CA3-2, CA1, and subiculum of AD (n = 14) preclinical AD (n = 8), and age-matched control subjects (n = 11). The results from the present study confirm our previous finding of significant neuronal losses in the CA1 (48%), hilus (14%), and subiculum (24%) in AD [Lancet 344 (1994) 769]. However, we did not observe a significant loss of neurons in CA1 or any of the other subdivisions of the hippocampus in preclinical AD.

Entities:  

Mesh:

Year:  2004        PMID: 15312966     DOI: 10.1016/j.neurobiolaging.2003.12.005

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  135 in total

1.  Alzheimer's disease and epilepsy: insight from animal models.

Authors:  Helen E Scharfman
Journal:  Future Neurol       Date:  2012-03-01

2.  In vivo MRI signatures of hippocampal subfield pathology in intractable epilepsy.

Authors:  Maged Goubran; Boris C Bernhardt; Diego Cantor-Rivera; Jonathan C Lau; Charlotte Blinston; Robert R Hammond; Sandrine de Ribaupierre; Jorge G Burneo; Seyed M Mirsattari; David A Steven; Andrew G Parrent; Andrea Bernasconi; Neda Bernasconi; Terry M Peters; Ali R Khan
Journal:  Hum Brain Mapp       Date:  2015-12-17       Impact factor: 5.038

3.  Familial risk for Alzheimer's disease alters fMRI activation patterns.

Authors:  Susan Spear Bassett; David M Yousem; Catherine Cristinzio; Ivana Kusevic; Michael A Yassa; Brian S Caffo; Scott L Zeger
Journal:  Brain       Date:  2006-05       Impact factor: 13.501

4.  Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons.

Authors:  Miguel Angel Riudavets; Diego Iacono; Susan M Resnick; Richard O'Brien; Alan B Zonderman; Lee J Martin; Gay Rudow; Olga Pletnikova; Juan C Troncoso
Journal:  Neurobiol Aging       Date:  2007-06-28       Impact factor: 4.673

5.  The szilard hypothesis on the nature of aging revisited.

Authors:  Henrik Zetterberg; Magnus Båth; Madeleine Zetterberg; Peter Bernhardt; Ola Hammarsten
Journal:  Genetics       Date:  2009-05       Impact factor: 4.562

6.  Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

Authors:  Joseph L Price; Daniel W McKeel; Virginia D Buckles; Catherine M Roe; Chengjie Xiong; Michael Grundman; Lawrence A Hansen; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Charles D Smith; Daron G Davis; Frederick A Schmitt; William R Markesbery; Jeffrey Kaye; Roger Kurlan; Christine Hulette; Brenda F Kurland; Roger Higdon; Walter Kukull; John C Morris
Journal:  Neurobiol Aging       Date:  2009-04-18       Impact factor: 4.673

Review 7.  Anti-dementia drugs and hippocampal-dependent memory in rodents.

Authors:  Carla M Yuede; Hongxin Dong; John G Csernansky
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

Review 8.  Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Stephanie L Leal; Michael A Yassa
Journal:  Ageing Res Rev       Date:  2013-02-04       Impact factor: 10.895

9.  Neuron loss associated with age but not Alzheimer's disease pathology in the chimpanzee brain.

Authors:  Melissa K Edler; Emily L Munger; Richard S Meindl; William D Hopkins; John J Ely; Joseph M Erwin; Elliott J Mufson; Patrick R Hof; Chet C Sherwood; Mary Ann Raghanti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-09-21       Impact factor: 6.237

Review 10.  Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

Authors:  Daniela Puzzo; Linda Lee; Agostino Palmeri; Giorgio Calabrese; Ottavio Arancio
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.